Synthesis and Evaluation of 3-Substituted-4-(quinoxalin-6-yl) Pyrazoles as TGF-β Type I Receptor Kinase Inhibitors

由 Zhao, Li-Min, Guo, Zhen, Xue, Yi-Jie, Min, Jun Zhe, Zhu, Wen-Jing, Li, Xiang-Yu, Piao, Hu-Ri, Jin, Cheng Hua
發表在 Molecules (2018)

Ginsenoside Rh2 attenuates microglial activation against toxoplasmic encephalitis via TLR4/NF-κB signaling pathway

由 Xu, Xiang, Jin, Lan, Jiang, Tong, Lu, Ying, Aosai, Fumie, Piao, Hu-Nan, Xu, Guang-Hua, Jin, Cheng-Hua, Jin, Xue-Jun, Ma, Juan, Piao, Lian-Xun
發表在 J Ginseng Res (2020)

P2X7 receptor‐targeted regulation by tetrahydroxystilbene glucoside in alcoholic hepatosteatosis: A new strategy towards macrophage–hepatocyte crosstalk

由 Zhang, Yu, Jiang, Min, Cui, Ben‐Wen, Jin, Cheng Hua, Wu, Yan‐Ling, Shang, Yue, Yang, Hong‐Xu, Wu, Mei, Liu, Jian, Qiao, Chun‐Ying, Zhan, Zi‐Ying, Ye, Huan, Zheng, Guang‐Hao, Jin, Quan, Lian, Li‐Hua, Nan, Ji‐Xing
發表在 Br J Pharmacol (2020)

Novel oral transforming growth factor‐β signaling inhibitor EW‐7197 eradicates CML‐initiating cells

由 Naka, Kazuhito, Ishihara, Kaori, Jomen, Yoshie, Jin, Cheng Hua, Kim, Dong‐Hyun, Gu, Yoon‐Kang, Jeong, Eun‐Sook, Li, Shaoguang, Krause, Daniela S., Kim, Dong‐Wook, Bae, Eunjin, Takihara, Yoshihiro, Hirao, Atsushi, Oshima, Hiroko, Oshima, Masanobu, Ooshima, Akira, Sheen, Yhun Yhong, Kim, Seong‐Jin, Kim, Dae‐Kee
發表在 Cancer Sci (2016)